Masimo appoints Rolf Classon to board of directors

MASIMO CORP

Rolf A. Classon appointed as a Class II director effective November 3, 2023.
Classon is a former Bayer HealthCare executive with board seats at Fresenius Medical Care, Catalent, and others.
Annual cash compensation of $70,000 plus initial RSU grant valued at $200,000 at next annual meeting.
No family relationships or related-party transactions with Masimo officers/directors.
Classon will help shape next stage of growth, per Chairman and CEO Joe Kiani.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rolf A. Classon

Class II Director

MASI · MASIMO CORP

Effective: 2023-11-03
Filed: November 7, 2023, 6:59 PM ET

On November 3, 2023, the Board of Directors (the “Board”) of Masimo Corporation (“Masimo”) appointed Rolf A. Classon as a Class II director of Masimo.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rolf A. Classon was appointed as Class II Director at MASIMO CORP.

Action: appointed
Role: Class II Director

Exact text from the filing

On November 3, 2023, the Board of Directors (the “Board”) of Masimo Corporation (“Masimo”) appointed Rolf A. Classon as a Class II director of Masimo.

View on SEC.gov

MASIMO CORP filing history →

Source: SEC EDGAR

accession 0000937556-23-000217

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.